Abbott, Reckitt and infant formula

Reckitt moves forward with Mead Johnson infant-formula disposal
CEO Kris Licht said last week that Reckitt has received “interest” from prospective buyers for its nutrition unit housing Mead Johnson.
Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Abbott stock falls following retrial order in infant formula case
The ruling overturned a previous verdict related to an infant formula case and has implications for both Abbott and Reckitt, with the latter’s shares also falling by 4.5%. The legal battle revolves around the Whitfield case, which pertains to the alleged link between infant formula and necrotizing enterocolitis (NEC) in premature infants.
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt Benckiser shares fell after a U.S. judge ordered a retrial of an infant-formula lawsuit that had found in the consumer-goods company's favor. In afternoon trading Friday, London-listed shares were down 2.
Reckitt says US court grants new trial in premature-infant formula case
Reckitt said on Friday a U.S. circuit court has ruled that a new trial could be sought by plaintiffs in a case that had accused the London-listed firm and Abbott of failing to warn of the risks of premature baby formulas.
Abbott, Reckitt Fall as Judge Grants New Trial on Infant Formula
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Abbott Labs and Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
Yahoo Finance6d
Reckitt still assessing options for Mead Johnson infant-formula “exit”
Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as "non-core" in July as part of a ...
Morningstar3mon
Reckitt Has a Strong Portfolio of Core Brands and Is Undergoing a Promising Transformation Journey
The majority of Reckitt’s portfolio is well positioned in categories that benefit from secular growth drivers across consumer health and hygiene. The acquisition of Mead Johnson has added to its ...
Seeking Alpha17d
Reckitt Benckiser Group: New Bull Run Initiated
Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on ...
Reckitt slumps on renewed litigation uncertainty - RBC Capital Markets
In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing ...
Consumer good giants Reckitt 'evaluating opportunities' for controversial baby formula brand Mead Johnson
Reckitt and rival Abbott Laboratories are defending more than 1,000 lawsuits alleging a connection between their milk-based ...
Reuters25d
Abbott Laboratories
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their ...
Reckitt hikes dividend for investors amid efficiency drive
On Wednesday, Reckitt said its operating profit fell 4.2 per cent to £2.43billion last year, while revenue fell 3 per cent to ...
Citi sees overturned verdict in state case as incrementally negative for Abbott
Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, which was in favor of Reckitt Benckiser’s (RBGLY) Mead ...